advanced search

Welcome: Guest

log in

The US Coagulation Market, 2009-2018

Publication Date September 2009
Publisher Venture Planning Grp.
Product Type Report
Pages 424
ISBN Number not applicable
Product Code VEP00230
Buy this product or for assistance call +44 20 7060 7474

Summary

This report presents a comprehensive analysis of the US coagulation market, including:

  • Major issues pertaining to the US coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Ten-year volume and sales forecasts for 40 coagulation procedures performed in US hospitals, commercial laboratories, and physician offices, including typical coagulation daily work loads.
  • Placement estimates for major automated and semiautomated systems.
  • Review of current instrumentation technologies, and a feature comparison of nearly 50 leading analyzers.
  • Ten-year reagent and instrument sales forecasts.
  • Sales and market shares of leading reagent and instrument suppliers.
  • Review of coagulation technologies and their potential market applications.
  • Major opportunities for coagulation instruments and consumables.
  • Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for instrument and reagent suppliers.

Content

  • USA:
    • A. Executive Summary
    • B. Business Environment
    • 1. Health Care Expenditures
    • 2. Cost Consciousness
    • 3. Reimbursement
    • 4. Industry Consolidation
    • 5. Managed Care
    • a. HMO
    • b. PPO
    • 6. Hospitals
    • 7. Admissions
    • 8. Length of Stay
    • 9. Industry Diversification
    • 10. Physician Demographics
    • 11. Population Aging
    • a. Chronic Illnesses
    • b. Disease Incidence
    • c. Susceptibility to Iatrogenesis
    • d. Multiple Illness Cases
    • 12. Laboratory Regulations
    • C. Market Structure
    • 1. Centralized Testing
    • a. Hospitals
    • b. Commercial laboratories
    • 2. Decentralized Testing
    • a. Physician Offices/Group Practices
    • b. Point-of-Care Testing
    • c. Home/Self Testing
    • d. Other Decentralized Testing Locations
    • D. Market Size, Growth And Major Suppliers
  • MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
  • DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
  • ALTERNATIVE MARKET PENETRATION STRATEGIES
    • A. Internal Development
    • B. Collaborative Arrangements
    • C. University Contracts
    • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types Of Distributors
    • 7. Market Segmentation
  • POTENTIAL MARKET ENTRY BARRIERS AND RISKS
    • A. Market Maturity
    • B. Cost Containment
    • C. Competition
    • D. Technological Edge And Limitations
    • E. Patent Protection
    • F. Regulatory Constraints
    • G. Decentralized Testing Market Challenges
  • COMPETITIVE ASSESSMENTS
    • Abbott
    • Agen Biomedical
    • American Diagnostica
    • American Labor
    • Axis-Shield
    • Beckman Coulter
    • Becton Dickinson
    • Biosite
    • Chronolog
    • Corgenix Medical
    • Diagen
    • Diagnostica Stago
    • Helena Laboratories
    • HemoSense/Inverness Medical Innovations
    • HYPEN BioMed
    • Instrumentation Laboratory
    • ITC
    • Medafor
    • Nanogen
    • Roche
    • Sarstedt
    • Siemens
    • Sienco
    • Sysmex
    • Thermo Fischer
    • Trinity Biotech
    • ZyCare
  • APPENDIXES
    • Appendix I: Major Companies Developing or
    • Marketing Coagulation Analyzers
    • Appendix II: Major Companies Developing or
    • Marketing Coagulation Calibrators and Controls
    • Appendix III: Major Companies Developing or
    • Marketing Platelet Aggregometers
    • Appendix IV: Assumed Currency Exchange Rates
  • LIST OF TABLES:
    • Major Companies Developing or Marketing Activated Clotting Time Tests
    • Major Companies Developing or Marketing APTT Tests
    • Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
    • Major Companies Developing or Marketing Antithrombin III Tests
    • Major Companies Developing or Marketing Bleeding Time Tests
    • Major Companies Developing or Marketing D-dimer Tests
    • Major Companies Developing or Marketing Factor Assays
    • Major Companies Developing or Marketing Fibrin Degradation Product Tests
    • Major Companies Developing or Marketing Fibrinogen Tests
    • Major Companies Developing or Marketing Heparin Tests
    • Major Companies Developing or Marketing Plasmin Tests
    • Major Companies Developing or Marketing Plasminogen Tests
    • Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
    • Major Companies Developing or Marketing Platelet Aggregation Tests
    • Major Companies Developing or Marketing Protein C Tests
    • Major Companies Developing or Marketing Protein S Tests
    • Major Companies Developing or Marketing PT Tests
    • Major Companies Developing or Marketing Thrombin Time Tests
    • Major Companies Developing or Marketing TPA Tests
    • Major Companies Developing or Marketing Von Willebrand's Factor Tests
    • Worldwide, All Market Segments, Laboratories Performing Coagulation Tests By Country, 2008
    • Worldwide, All Market Segments, Total Coagulation Test Volume By Country, 2008-2018
    • Worldwide, All Market Segments, Total Coagulation Reagent Market By Country, 2008-2018
    • Worldwide, All Market Segments, Total Coagulation Instrument Market By Country, 2008-2018
    • Worldwide, All Market Segments, Total Coagulation Diagnostics Market By Country, 2008-2018
    • Executive Summary Table: U.S.A., Total Coagulation Diagnostics Market By Market Segment and Product Category, 2008-2018
    • U.S.A., Laboratories Performing Coagulation Tests By Market Segment, 2008
    • U.S.A., Hospital Laboratories Performing Coagulation Tests By Bed Size, 2008
    • U.S.A., Commercial/Private Laboratories Performing Coagulation Tests By Annual Test Volume, 2008
    • U.S.A., Physician Offices/Group Practices Performing Coagulation Tests By Practice Size, 2008
    • U.S.A., Hospital Laboratories Average Daily Test Volume, 2008
    • U.S.A., Commercial/Private Laboratories Average Daily Test Volume, 2008
    • U.S.A., Physician Offices/Group Practices Average Daily Test Volume
    • U.S.A., Total Coagulation Test Volume By Market Segment, 2008-2018
    • U.S.A., All Market Segments Coagulation Test Volume, 2008-2018
    • U.S.A., Hospital Laboratories Coagulation Test Volume, 2008-2018
    • U.S.A., Physician Offices/Group Practices Coagulation Test Volume, 2008-2018
    • U.S.A., Commercial/Private Laboratories Coagulation Test Volume, 2008-2018
    • U.S.A., Coagulation Reagent Market By Market Segment, 2008-2018
    • U.S.A., Major Suppliers of Coagulation Reagents Estimated Sales and Market Shares, 2008
    • U.S.A., Coagulation Instrument Market By Market Segment, 2008-2018
    • U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Total Instrument Placements and Market Shares, 2008
    • U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Placements and Installed Base By Supplier and Model, 2008
    • U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares, 2008
    • U.S.A., Total Coagulation Diagnostics Market By Product Category, 2008-2018
    • U.S.A., Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares, 2008
Delivery Details

PDF:Delivered by email usually within 12 to 24 UK business hours.

Industry Events

2nd International Conference on Drug Discovery and Therapy

01 Feb 10 to 04 Feb 10
Dubai, United Arab Emirates
view summary >>

Oncology Market & Patient Access

14 Dec 09 to 16 Dec 09
Prague, Czech Republic
view summary >>